Title of Study: A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Fast Facts:
Protocol number:
BM18106
Sponsor:
Hoffmann-La Roche
Company division:
Pharmaceutical
Product name:
DPP-IV Inhibitor
Phase of development:
II
Therapeutic area, approved indication:
Diabetes Mellitus, Type 2
Date of report:
6/22/2007
Clinical study summary: No data will be posted since Roche made a strategic decision to terminate the project. The decision was based on available clinical data, indicating that the compound does not provide enough clinical differentiation from other anti-diabetic therapy currently available, and was not due to an unacceptable safety profile .
This site is run by CenterWatch, a publishing company that focuses on the clinical Trial Listings industry. The information provided in this service is designed to help patients find clinical Trial Results that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these Trial Listings.
Trial Results updated:
September 29, 2008 at 10:25:37 AM
